Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinyue Han

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Scientific Reports|December 31, 2024
Dissociated response and treatment outcome with immune checkpoint blockade in advanced cancerYaping Guan, Yu Cui, Yanhong Gong, et al.
BMC Infectious Diseases|March 22, 2024
How does the SARS-CoV-2 reinfection rate change over time? The global evidence from systematic review and meta-analysisYing Chen, Wenhui Zhu, Xinyue Han, et al.
Genes & Diseases|February 12, 2026
Salt-inducible kinase 1 is a key gene in suppressing EVD68-induced asthma by modulating antiviral immunityJuntong Liu, Yue Wang, Lingyun Zou, et al.
International Journal of Pharmaceutics: X|October 27, 2025
A novel EGFR-targeted photosensitizer for the theranostics of skin cancerHuijuan Li, Huijun Li, Shuang Qi, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
High-resolution MRI Guided Whole Mouse Brain Cell Type Atlas using Deep LearningXinyue Han, Rui Hu, Zhuoheng Liu, et al.
Viruses|February 26, 2025
NAD+ Suppresses EV-D68 Infection by Enhancing Anti-Viral Effect of SIRT1Yue Wang, Haiyu Li, Xia Huang, et al.
Angewandte Chemie (International Ed. in English)|September 6, 2025
A Facile and Efficient Route to Achieve Polythiophene-Based Nanoparticles With Various MorphologiesTianyu Zhang, Qingqing Hu, Jiaqi Yu, et al.
Virologica Sinica|July 23, 2025
ARRDC3 promotes lysosome-mediated YAP degradation to inhibit enterovirus replicationXia Huang, Siyuan Wang, Yan Huang, et al.
BMC Infectious Diseases|August 15, 2024
A novel method to select time-varying multivariate time series models for the surveillance of infectious diseasesJie Yu, Huimin Wang, Miaoshuang Chen, et al.
BMC Cancer|January 25, 2025
Organ-specific immune-related adverse events and prognosis in cancer patients receiving immune checkpoint inhibitorsXinyue Han, Yingcui Chen, Hong Xie, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Scientific Reports|December 31, 2024
Dissociated response and treatment outcome with immune checkpoint blockade in advanced cancerYaping Guan, Yu Cui, Yanhong Gong, et al.
BMC Infectious Diseases|March 22, 2024
How does the SARS-CoV-2 reinfection rate change over time? The global evidence from systematic review and meta-analysisYing Chen, Wenhui Zhu, Xinyue Han, et al.
Genes & Diseases|February 12, 2026
Salt-inducible kinase 1 is a key gene in suppressing EVD68-induced asthma by modulating antiviral immunityJuntong Liu, Yue Wang, Lingyun Zou, et al.
International Journal of Pharmaceutics: X|October 27, 2025
A novel EGFR-targeted photosensitizer for the theranostics of skin cancerHuijuan Li, Huijun Li, Shuang Qi, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
High-resolution MRI Guided Whole Mouse Brain Cell Type Atlas using Deep LearningXinyue Han, Rui Hu, Zhuoheng Liu, et al.
Viruses|February 26, 2025
NAD+ Suppresses EV-D68 Infection by Enhancing Anti-Viral Effect of SIRT1Yue Wang, Haiyu Li, Xia Huang, et al.
Angewandte Chemie (International Ed. in English)|September 6, 2025
A Facile and Efficient Route to Achieve Polythiophene-Based Nanoparticles With Various MorphologiesTianyu Zhang, Qingqing Hu, Jiaqi Yu, et al.
Virologica Sinica|July 23, 2025
ARRDC3 promotes lysosome-mediated YAP degradation to inhibit enterovirus replicationXia Huang, Siyuan Wang, Yan Huang, et al.
BMC Infectious Diseases|August 15, 2024
A novel method to select time-varying multivariate time series models for the surveillance of infectious diseasesJie Yu, Huimin Wang, Miaoshuang Chen, et al.
BMC Cancer|January 25, 2025
Organ-specific immune-related adverse events and prognosis in cancer patients receiving immune checkpoint inhibitorsXinyue Han, Yingcui Chen, Hong Xie, et al.
Pageof 7